Company news
Zentalis Pharmaceuticals, Inc. news in 2023
Zentalis Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
November 5, 2023
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
August 8, 2023
Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
July 31, 2023
Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock
June 14, 2023
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
June 5, 2023
Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting
May 24, 2023
Zentalis to Host Investor Call to Provide Clinical Update with Safety, Pharmacology, and Efficacy Results for Azenosertib Monotherapy and Development Plans for Monotherapy and Chemotherapy Combinations
May 22, 2023
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
May 9, 2023
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
April 25, 2023
Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
April 16, 2023
Zentalis Pharmaceuticals Reports Full Year 2022 Financial Results and Operational Updates
February 28, 2023
Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer
February 12, 2023
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
January 31, 2023
Decks in 2023
- Investor Presentation (November 2023)
Investor deck · 55 slides · Nov 6, 2023
- Investor Presentation (September 2023)
Investor deck · 43 slides · Sep 13, 2023
- Investor Presentation (August 2023)
Investor deck · 47 slides · Aug 9, 2023
- Corporate Update (June 2023)
Corporate update · 53 slides · Jun 6, 2023
- Investor Presentation (June 2023)
Investor deck · 47 slides · Jun 6, 2023
- Investor Presentation (April 2023)
Investor deck · 55 slides · Apr 17, 2023
- Investor Presentation (March 2023)
Investor deck · 53 slides · Mar 1, 2023
- Investor Presentation (January 2023)
Investor deck · 56 slides · Jan 9, 2023